A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

✍ Scribed by Bin Nie; Wan-Jun Cheng; Yan-Fang Li; Zheng Cao; Qing Yang; Ying-Xin Zhao; Yong-He Guo; Yu-Jie Zhou

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 174 KB
• Volume: 72
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/ccd.21713